Yeon‐Sil Kim

Ulsan College — South Korea

Medicine · Health Sciences

26h-index2.1kcitations146works1.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(42), Lung Cancer Treatments and Mutations(30), Lung Cancer Diagnosis and Treatment(29), Advanced Radiotherapy Techniques(23), Lung Cancer Research Studies(18)

Publications146 total

Tumour budding in pretreatment cervical biopsies: a prognosticator for personalised therapy in the era of precision oncology
Histopathology·2025
Can lymphocytic toxicity be induced by radiation dose to the bowel bag in whole pelvic radiotherapy?
Radiation Oncology Journal·2025Open Access
Radiotherapy quality assurance program of ongoing clinical trial using stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC): a dummy run study of a prospective, randomized, multicenter phase III trial (KGOG 3064/KROG 2204)
BMC Cancer·2025Open Access
Postoperative conventional versus hypofractionated intensity-modulated radiation therapy with concurrent chemotherapy in cervical cancer: a prospective multicenter randomized phase III trial (POHIM_P3 trial)
Journal of Gynecologic Oncology·2025· 1 citedOpen Access
High-Risk Early-Stage Endometrial Cancer: Role of Adjuvant Therapy and Prognostic Factors Affecting Survival
Cancers·2025· 3 citedOpen Access
Abstract LB284: VRN101099: A novel treatment option for HER2-driven cancer patients, overcoming T-DXd resistance and brain metastases
Cancer Research·2025
Abstract CT136: First-in-human studies of VRN110755 in NSCLC patients with EGFR mutations: Safety, pharmacokinetics, and early efficacy assessment
Cancer Research·2025
Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 4: Liver and locally recurrent rectal cancer
Radiation Oncology Journal·2024· 1 citedOpen Access
Radiation Therapy for Graves’ Ophthalmopathy: When Is the Optimal Timing of Treatment and Evaluation
Practical Radiation Oncology·2024Open Access
Mid-treatment MRI-based tumor response assessment for tumor recurrence and patient survival in locally advanced adenocarcinoma of the cervix: A retrospective multicenter study of KROG 23-03
Gynecologic Oncology·2024· 1 cited
Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 3. Genitourinary and gynecological cancers
Radiation Oncology Journal·2024· 5 citedOpen Access
Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 2. Lung (non-small cell lung cancer)
Radiation Oncology Journal·2024· 1 citedOpen Access
2360: Radiotherapy for Graves’ Ophthalmopathy: clinical outcome, efficacy, and optimal timing
Radiotherapy and Oncology·2024
Safety and Efficacy of HL301 In Radiation Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer Receiving Curative Concurrent Chemoradiotherapy: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 2a Clinical Trial
International Journal of Radiation Oncology*Biology*Physics·2024
Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 1. Brain and head and neck
Radiation Oncology Journal·2024· 4 citedOpen Access
Diagnostic assessments and treatment results of well-differentiated gastric-type adenocarcinoma of the uterine cervix (Adenoma malignum): A multicenter retrospective analysis of KROG 22-03 study
Gynecologic Oncology·2024· 3 cited
When Should Spinal Surgery Be Considered for Spinal Metastasis from Non-Small Cell Lung Cancer?—Propensity Score Matched Study between Surgery with Radiotherapy and Radiotherapy Alone
Journal of Clinical Medicine·2023· 2 citedOpen Access
The Updated World Health Organization Classification Better Predicts Survival in Patients With Endocervical Adenocarcinoma (KROG 20-07)
International Journal of Radiation Oncology*Biology*Physics·2023· 5 cited
Current Evidence of a Deintensification Strategy for Patients with HPV-Related Oropharyngeal Cancer
Cancers·2022· 15 citedOpen Access
Importance of lymph node ratio in HPV-related oropharyngeal cancer patients treated with surgery and adjuvant treatment
PLoS ONE·2022· 4 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Jin‐Hyoung Kang(11), Jin Hyoung Kang(9), Sea-Won Lee(9), Sei‐Chul Yoon(8), Chang Geol Lee(8), Ie Ryung Yoo(8), Jong Hoon Lee(8), Yun Hee Lee(7), Kyo Young Lee(7), Min‐Sik Kim(6), Ki Chang Keum(6), Yong Chan Ahn(6), Young Kyoon Kim(6), Sook Hee Hong(5), Sung Ho Moon(5), Kwan Ho Cho(5), Dongryul Oh(5), Hong Seok Jang(5), Dong‐Il Sun(4), Sang Nam Lee(4)